Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Selexis to Participate at Several Upcoming Industry Conferences

Selexis SA
Posted on: 05 Sep 17

Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today its planned participation at upcoming industry conferences, as follows:

BioProcess International Conference
25 – 28 September 2017, Hynes Convention Center, Boston, USA
Selexis will attend the conference and exhibit along with KBI Biopharma.
For more information, please visit:

23 rd  Annual Partnering Conference BIO Europe
6 – 8 November 2017, CityCube Berlin, Berlin, Germany
Selexis will sponsor the conference and participate in the partnering program.
For more information, please visit:

9 th  Annual PEGS Europe Protein & Engineering Summit
13 – 17 November 2017, EPIC SANA Lisboa Hotel, Lisbon, Portugal
Selexis Chief Scientific Officer Pierre-Alain Girod, PhD will present “Genome-Wide Signals Detection for Enhanced Cell Line Productivity and Stability” on Thursday, 16 November at 10:05 a.m. WET as part of the Expression track. Additionally, Selexis is a conference sponsor and exhibitor.
For more information, please visit:

About Selexis SA

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients. Selexis’ SUREtechnology Platform™ facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the bioproduction continuum, spanning discovery to commercialization. With more than 100 partners worldwide, 80+ drug products in clinical development and three commercial products utilizing Selexis-generated cell lines, the Company has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research. More information is available at



- Web

- LinkedIn

- Twitter

- Facebook


View source version on

Business Wire

Last updated on: 05/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.